Shares of Moderna Inc. mRNA,
fell 9.72% to $ 111.40 on Monday in what turned out to be a generally favorable stock market trading session with the NASDAQ Composite Index COMP,
increasing by 0.74% to 12,899.42, and the DJIA Dow Jones industrial average,
increasing by 0.68% to 30,403.97. This was the second consecutive day of stock losses. Moderna Inc. closed at $ 67.10 below the 52-week high ($ 178.50), which the company hit on Dec. 1.
The stock performed poorly compared to some of its competitors on Monday, such as AbbVie Inc. Abbvie,
rose 0.18% to $ 103.45, Amgen Inc. AMGN,
increased by 0.32% to USD 223.65, and AstraZeneca PLC ADR AZN,
rose 1.77% to $ 49.38. The trading volume (EUR 30.7 million) overshadowed the 50-day average volume of 23.1 M.
Editor’s note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See the terms of use of our market data.